developmental defects are rescued using an aryl hydrocarbon receptor (AHR) antagonist (CH223191), suggesting that mITP-induced toxicity was AHR-dependent. As zebrafish have three known AHR isoforms, we used a functional AHR2 knockout line along with AHR1A-and AHR1B-specific morpholinos to determine which AHR isoform, if any, mediates mITPinduced cardiotoxicity. As in silico structural homology modeling predicted that mITP may bind favorably to both AHR2 and AHR1B isoforms, we evaluated AHR involvement in vivo by measuring CYP1A mRNA and protein expression following exposure to mITP in the presence or absence of CH223191 or AHR-specific morpholinos. Based on these studies, we found that mITP interacts with both AHR2 and AHR1B isoforms to induce CYP1A expression. However, while CH223191 blocked mITP-induced CYP1A induction and cardiotoxicity, knockdown of all three AHR isoforms failed to block mITP-induced cardiotoxicity in the absence of detectable CYP1A induction. Overall, these results suggest that, while mITP is an AHR agonist, mITP causes AHR-independent cardiotoxicity through a pathway that is also antagonized by CH223191.
INTRODUCTION
In 2004, the commercial polybrominated diphenyl ether (PBDE) mixture known as PentaBDE -a widely used brominated flame retardant (FR) -was voluntarily phased out in the United States due to concerns about persistence, bioaccumulation, and toxicity (Rahman et al., 2001; Tullo, 2003) . As a result of strict fire safety standards set for lowdensity polyurethane foam in residential furniture and baby products, brominated and aryl phosphate ester (APE) components of the replacement FR mixture formulation known as using an AHR2-specific translation-blocking morpholino (MO). However, AHR2 knockdown failed to block mITP-induced cardiac abnormalities, suggesting that this phenotype was mediated through an AHR2-independent pathway.
As mITP-induced cardiotoxicity and CYP1A induction were blocked by CH223191 but not AHR2 knockdown, one of the key questions arising from this study was whether cardiotoxicity is mediated by an AHR1A and/or AHR1B-dependent pathway. Therefore, we first used in silico structural modeling -an approach previously used to predict AHR ligand binding (Bisson et al., 2009; Goodale et al., 2012) -to determine whether mITP would dock favorably with the AHR2, AHR1A, and AHR1B ligand-binding domains (LBDs). In vivo studies using zebrafish were then conducted to determine whether AHR1A and/or AHR1B contribute to mITP-induced cardiotoxicity during early embryonic development. In order to eliminate the potential for incomplete AHR2 knockdown with transient MOs, and to better investigate the individual roles of AHR1A and AHR1B isoforms, a functional zebrafish AHR2 knockout line was utilized. (Figure 1 ) was originally provided as FM550 (Chemtura) via Dr. Susan Klosterhaus (Cradle to Cradle Products Innovation Institute, San Francisco, CA) and was purified by Wellington Laboratories (Guelph, Ontario, Canada) as previously described (McGee et al., 2013) . Due to the lack of commercially available analytical standards for mITPs, exact ratios of mITP congeners (ortho, meta, para) within our mITP fraction are unknown. The AHR antagonist, 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH223191, >99%) (Figure 1 ), was purchased from Tocris Bioscience (Ellisville, MO). All stock solutions were dissolved in ACS-grade dimethyl sulfoxide (DMSO).
MATERIALS AND METHODS

Chemicals. mITP (≥ 90%)
Zebrafish lines and embryos.
All adult zebrafish were housed in accordance to approved Institutional Animal Care and Use Committee (IACUC) protocols at Oregon State University on a recirculating water system at 28±1˚C with a 14-h light/10-h dark schedule.
Embryos from adult 5D zebrafish were obtained from group spawns as previously described (Reimers et al., 2006 Modified intermolecular terms such as soft van der Waals, hydrogen bonding, and hydrophobicity were added. Conformational sampling was based on the biased probability Monte Carlo (BPMC) procedure, which randomly selects a conformation in the internal coordinate space and then initiates a step to a new random position independent of the previous one -but according to a predefined continuous probability distribution -since, after each random step, full local minimization greatly improves the efficiency of the procedure. In the ICM-VLS (Molsoft ICM) screening procedure, the ligand scoring was optimized to obtain maximal separation between binders and non-binders. Based on fit within the receptor, each compound was assigned an ICM score that accounts for continuum and discreet electrostatics as well as hydrophobicity and entropy parameters (Totrov and Abagyan, 2001; Abagyan et al., 1994 ).
mITP exposures and developmental toxicity assessments. mITP exposures were
conducted using a static exposure protocol. Embryos were batch-exposed with chorions intact in 20-mL glass vials. Vials were prewashed with Liquinox ® and hot water, and then RO-rinsed. Vials were loaded with 10 viable embryos (6-to-8 hpf) using polished glass pipettes, and 7 mL of mITP or vehicle control (0.1% DMSO) in E2 embryo medium was added. Each treatment group consisted of three replicate vials that were incubated at 28±1˚C with a 14-h light/10-h dark schedule until 72 hpf for qPCR and immunohistochemistry experiments and 120 hpf for concentration-response and CH22391
studies.
Preliminary range-finding studies were conducted at intervals between 0.1 and 1.6 μM mITP, monitored daily, and screened closely for malformations at 120 hpf. Necrotic embryos were removed daily. Based on these range-finding studies, the 0.2 μM mITP concentration was selected for the remaining experiments because it was the lowest concentration where pericardial edema was easily discernable, CYP1A induction was strong, and CYP1A induction was rescued with AHR knockdown. At 120 hpf, fish were evaluated for absence or presence of pericardial edema and euthanized via prolonged immersion within an overdose of tricaine methanesulfonate (MS-222).
CH223191 co-exposures.
We first used CH223191 -an AHR antagonist (Kim et al. embryos were pre-exposed to either 20 mL of 0.5 μM CH223191 or 0.1% DMSO in glass petri dishes from 0.75 to 6 hpf. At 6 hpf, 10 embryos per replicate (three replicate vials per treatment) were moved to 20 mL glass vials and treated with 7 mL of 0.1% DMSO or 0.2 μM mITP in the absence or presence of 0.5 μM CH223191 using a static exposure protocol.
Vials were incubated at 28±1˚C with a 14-h light/10-h dark schedule until 120 hpf. Necrotic embryos were removed daily. At 120 hpf, fish were evaluated for the absence or presence of pericardial edema and then euthanized with MS-222.
Morpholino injections.
Fluorescein-tagged MO anti-sense oligonucleotides were designed against AHR1A and AHR1B zebrafish isoforms and purchased from Gene Tools 
Immunohistochemistry. Before performing immunohistochemistry (IHC), 72-hpf 5D
and ahr2 hu3335 embryos were fixed in 4% paraformaldehyde overnight on a rocker at 4°C.
Fixed embryos were then washed twice with phosphate-buffered saline with Tween ® 20
(PBST) for 30 min, DI water for 1 hour, and placed in -20°C in acetone and ice for 20 min.
Samples were then treated with collagenase (1 mg/mL within PBST) for 50 min, then washed twice with PBST for 30 min, and treated with 10% normal goat serum (NGS) for 1 hour. Samples were then treated with a Biosense mouse α fish CYP1A monoclonal primary antibody (1:500 dilution in 10% NGS) and incubated overnight at 4°C on a rocker. On day two, embryos were rinsed three times in PBST for 30 min and treated with an Alexa Fluor 594 goat α mouse secondary antibody (1:1000 dilution in 10% NGS) for 2 hours on a rocker at room temperature. Embryos were rinsed three times with PBST before imaging. Supernatant was removed and 500 μL isopropanol was added, vortexed, and centrifuged at 12,000 rpm for 10 min. The resulting RNA pellet was then washed three times in 75%
ethanol and centrifuged at 8,000 rpm for 3 min between washes. The pellet was dissolved in 20 μL water and total RNA concentration was measured using SynergyMx microplate reader (Biotek) with the Gen5 Take3 module. Total RNA was then diluted to 200 ng/μL, and singlestrand cDNA was generated using a high-capacity cDNA Reverse Transcription kit (Applied Biosystems) with MultiScribe™ Reverse Transcriptase per manufacturer's instructions. All resulting cDNA was stored at -20°C until use.
Relative abundance of cyp1a, ahr1a, ahr1b, and β-actin, mRNA transcripts was measured for each exposure scenario using real-time qPCR. All primer sequences utilized in this study were previously used in Goodale et al. (2012) and are listed in 
RESULTS
mITP is predicted to bind AHR2 and AHR1B but not AHR1A
TCDD, CH223191 and the ortho-, meta-and para-mITP congeners were docked into hAHR and zebrafish AHR2, AHR1B and AHR1A models ( Table 2 CH223191 docked with a score of -13.99 also involving the side chain of Ser 365 (Table 2 , Table 2 , Fig. 1C,D) . The ortho congener docked but did not bind favorably to hAHR (Table 2) .
TCDD and the mITP congeners were also docked within each zebrafish AHR isoform. In AHR2, the human residue Ser 365 is replaced by an alanine (Bisson et al., 2009 ). TCDD docked similarly in both tautomerization states of His 296 docking with a score of -21.86 (His-E) and established a HB with the side chain of Gln 388 (Table 2 , Fig. 1E ).
CH223191 docked with a score of -12.04 also interacting with the side chain of Gln 388 (Table 2 , Fig. 1F ). All three mITP congeners docked in the binding pocket of AHR2 in both tautomerization states of His 296. The meta congener produced the highest score of -10.67
(His-E), establishing a HB with the side chain of His 296 (Table 2 , Fig. 1G ). The para (Fig.   1H ) and ortho congeners both docked but did not bind favorably (Table 2 ).
In AHR1B, the human residue Ser 365 is replaced by an alanine (Bisson et al. 2009 ).
TCDD docked similarly in both tautomerization states of His 296 with a score of -17.48 (His-E, Table 2 , Fig. 1I ). CH223191 and the meta-and para-mITP congeners docked in the binding pocket in both tautomerization states of His 296. CH223191 docked with a score of -17.87 (Table 2 , Fig. 1J ), whereas the meta-and para-mITP congeners docked with scores of -13.08 and -9.51 in the His-E tautomerization state, respectively, establishing a double HB with the side chain of Asn 341 ( Table 2 , Fig. 1K,L) . The ortho congener did not dock. In the AHR1A residue, Tyr 296 replaces His 296, which is conserved in AHR2 and AHR1B, but Table 2 ). The ortho-and para-mITP congeners did not dock. CH223191 and the meta congener docked with an unfavorable score (Table 2) , establishing an HB interaction with the side chain of Tyr 296.
Overall, these data suggest that the meta-and para-mITP congeners possess favorable binding towards hAHR and zebrafish AHR2 and AHR1B, but not AHR1A. In order to begin determining whether mITP interacts with one or more AHR isoforms, we injected 5D and ahr2 hu3335 embryos with control MO (CoMO), and ahr2 hu3335 embryos with either AHR1B MO or both AHR1A and AHR1B MOs. All groups were then treated with either vehicle or 0.2 μM mITP. In 5D embryos injected with CoMO, 100%
AHR knockdown does not prevent mITP-induced cardiotoxicity
exhibited PE (Fig. 2B) . Surprisingly, all mITP-exposed ahr2 hu3335 morphants also showed severe PE in the majority of embryos ( Fig. 2A,B) . In ahr2 hu3335 mutant larvae injected with either CoMO, AHR1B MO, or co-injected with both AHR1A and AHR1B MO, there was 100%, 76%, and 80% PE, respectively ( Fig. 2A,B) . In the AHR1B/ahr2 hu3335 morphants, there was a statistically significant decrease in PE relative to 5D or ahr2 hu3335 embryos injected with CoMO but no decrease relative to ahr2 hu3335 co-injected with both AHR1A and AHR1B MOs. Therefore, these data suggest that neither AHR2, AHR1A, nor AHR1B play a role in mediating mITP-induced cardiotoxicity. Dagger ( †) denotes a statistically significant increase in PE in mITP-exposed embryos relative to vehicle controls within the same group (p < 0.05), whereas double dagger ( ‡) denotes a statistically significant decrease in PE relative to mITP-exposed CoMO-injected WT fish (p < 0.05). N = 3 replicate vials and 9 to 10 fish per replicate.
mITP-induced CYP1A expression is AHR2-and AHR1B-dependent
Although AHR knockdown failed to block mITP-induced cardiotoxicity, we tested the reliability of our in silico docking findings by evaluating CYP1A expression in vivo. Though we were unable to separate the mITP mixture into individual congeners for this study, we used the mITP mixture to determine AHR isoform dependence. To do this, we utilized IHC and real-time qPCR to measure CYP1A induction at 72 hpf in all AHR knockdown scenarios. First, IHC indicated that 5D embryos injected with CoMO and exposed to vehicle exhibited no detectable CYP1A protein induction, while mITP-exposed embryos showed strong CYP1A protein induction in the vasculature, heart, and liver (Fig. 3A) . On the other hand, mITP-exposed ahr2 hu3335 mutants injected with CoMO, AHR1B MO, and co-injected with both AHR1A and AHR1B MOs exhibited no detectable CYP1A protein induction using IHC, suggesting that AHR2 is activated by mITP (Fig. 3A) . Using real-time qPCR to measure CYP1A mRNA, however, we found that ahr2 hu3335 CoMO-injected mutants had a 18-fold increase in CYP1A expression in mITP-exposed embryos relative to vehicle controls (Fig.   3B ). In the presence of AHR1B knockdown, CYP1A induction returned to AHR1B/ahr2 hu3335 morphant vehicle control levels (Fig. 3B ). In addition, triple knockdown of AHR2, AHR1A, and AHR1B isoforms showed no further reduction in CYP1A induction relative to vehicle control levels in the same group (Fig. 3B) , and this suggests that AHR1A does not play a role in mITP-induced CYP1A expression. Lastly, using qualitative PCR to measure ahr1a
and ahr1b mRNA, we found that MO-injected embryos had an intron deleted or inserted, respectively, which suggests each isoform was successfully knocked down (Fig. 4) . Overall, these data suggest that AHR2 and AHR1B isoforms both contribute to mITP-induced CYP1A expression. fragments spanning the MO target sites were amplified using PCR. cDNA was from identical 72-hpf embryos that were used for CYP1A qPCR.
DISCUSSION
Using in silico structural homology modeling, TCDD was predicted to dock to AHR2 and AHR1B LBDs, but not AHR1A -which has been shown previously both in vivo and in vitro (Andreasen et al., 2002; Goodale et al., 2012; Karchner et al., 2005) . Comparing only docking scores with TCDD within each AHR isoform model, we predicted that AHR2 and AHR1B -but not AHR1A -would bind both CH223191 and mITP ( Table 2) . As mITP is a mixture of meta-, para-, and ortho-substituted mITP congeners, we tested whether these three congeners may dock to hAHR and zebrafish AHR1A, AHR1B, and AHR2 in silico, and found that meta-mITP weakly docked to hAHR and zebrafish AHR2 and AHR1B, while paramITP weakly docked to human AHR and zebrafish AHR1B. Previously, McGee et al. (2013) used an in vitro human AHR reporter assay and demonstrated that mITP exposure resulted in activation of hAHR-dependent transcription. However, because of the current lack of commercially available analytical standards for mITP congeners, we were unable to separate mITP into its individual congeners to test the hypothesis that meta and para -but not ortho -activates AHR2 and AHR1B isoforms as was predicted in silico. Moreover, it is important to note that the mITP sample used in this study is from one batch of FM550 and, as a result, the ratio of individual congeners may vary from batch to batch.
The AHR is known for its promiscuity and various functional activities, including crosstalk with other receptors and differential expression of AHR response elements with various exogenous ligands (Denison et al., 2011) . Therefore, understanding the role of the AHR in developmental toxicity can often be complicated. Utilizing CH223191 as a pharmacologic tool, we confirmed results seen in McGee et al. (2013) that suggested mITPinduced cardiotoxicity was AHR-dependent. However, using ahr2 hu3335 zebrafish along with AHR1A and AHR1B MOs, we were able to more clearly determine the role of the AHR in mITP-induced cardiotoxicity. In Goodale et al. (2012) , ahr2 hu3335 zebrafish were successfully utilized to rescue severe TCDD-induced developmental toxicity normally observed in wildtype zebrafish at the same nominal concentrations. Also, for the first time, Goodale et al.
(2012) knocked down all three zebrafish AHR isoforms and, as a result, rescued leflunomide-induced CYP1A expression that activated all three AHR isoforms. In a similar way, we were able to knockdown all three AHR isoforms to study the interaction between mITP and AHR and to determine whether this interaction results in cardiotoxicity in zebrafish. As a result, we found that mITP-induced CYP1A expression is certainly mediated through the AHR2 and AHR1B isoforms, but that cardiotoxicity is AHR-independent.
Real-time qPCR results showed that CYP1A mRNA expression returned to AHR1B/ahr2 hu3335 morphant vehicle control levels upon AHR2 and AHR1B knockdown and that knockdown of all three AHR isoforms together did not further affect CYP1A expression.
In addition, IHC results showed that 5D zebrafish had strong CYP1A protein induction indicative of AHR2 activation (Goodale et al. 2012 suggest that CH223191 antagonizes another target in addition to AHR that results in the protection from the induction of cardiotoxicity, and that these other targets should be evaluated before CH223191 is used again to study AHR specifically. In summary, the findings in the present study show that additional research is needed to elucidate the developmental toxicity of mITP and FM550 more broadly.
Previously, because of concerns about brominated FRs, the halogenated components of FM550 were investigated first. Specifically, TBPH has been shown to cause thyroid, liver, and testis toxicity in developing rodents, and TBB and TBPH have both been demonstrated to be endocrine disruptors at environmentally relevant levels (Springer et al., 2012; Patisaul et al., 2013) . The present study is only the second to look specifically at the potential health effects from mITP. Though we showed mITP is an AHR agonist that causes AHRindependent cardiotoxicity in zebrafish, little is known regarding the downstream mechanisms. Given the widespread use of mITP and other APEs (particularly TPP), a more thorough evaluation of mITP should be undertaken in order to determine the potential human health and ecological risks.
SUPPLEMENTARY DATA
Primers for real-time qPCR as well as initial results from mITP concentration-response and CH223191 co-exposures are provided within Supplementary File 1.
